Real-time enrollment status for this stargardt disease clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:38 AM UTC
| NCT Number | NCT07425574 |
| Recruiting Status | Recruiting |
| Condition | Stargardt Disease |
| Phase | Clinical Trial |
| Target Enrollment | 90 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | June 24, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT07425574 is currently recruiting participants. This clinical trial study for stargardt disease is actively seeking new participants at 11 locations across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07425574 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07425574 was last updated 2 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.